Simon Brain Fishel

Anecova SA provides research and development in fertility treatment. The firm’s device restores the fertilization and early embryonic development phases back into the physiologic environment of the maternal uterus. The company was founded by Martin Velasco and Pascal Mock in 2004 and is headquartered in Lausanne, Switzerland.

Axordia Ltd. develops human embryonic stem cell applications. Its applications include dry AMD, next generation stents, and GMP-compliant HESC lines. The company was founded by Peter W. Andrews and Harry Moore in 2001 and is headquartered in Sheffield, UK.

Sure Laboratories is an independent clinical cytogenetic service laboratory providing dedicated microarray based comparative genomic hybridization (arrayCGH) screening for detection of copy number imbalance and aneuploidy. It is established by BlueGnome to ensure fast turnaround and high quality results, maintaining a clear workflow and SOPs for the sole purpose of delivering the highest clinical standards. It offers services, such as PGS screening of single cells for aneuploidy, unbalanced translocations associated with repeated IVF failure and recurrent miscarriage or congenital anomalies where structural chromosomal abnormalities are suspected. The company was founded in 2010 and is headquartered in Cambridge, GB

Care Fertility Group Ltd. provides fertility services. It offers fertility treatment, genetic diagnosis, and associated fertility preservation procedures. The company was founded by Simon Brian Fishel, Kenneth Dowell, and Simon Thornton in 1997 and is headquartered in Nottingham, the United Kingdom.